Relatório global de análise do tamanho, quota e tendências do mercado de hormonas bioidênticas – Visão geral do setor e previsão para 2031

Análise de mercado de hormonas bioidênticas

No ritmo acelerado e stressante de hoje, experimentar desequilíbrio hormonal é normal, especialmente nas mulheres. Com vários tipos de alterações hormonais, o organismo feminino desenvolve doenças e anomalias que são agravadas pelo envelhecimento. O desequilíbrio hormonal provoca problemas como o aumento de peso, declínio da memória, fadiga e perda muscular.

Tamanho do mercado de hormonas bioidênticas

O tamanho global do mercado das hormonas bioidênticas foi avaliado em 3,81 mil milhões de dólares em 2023 e deverá atingir os 6,35 mil milhões de dólares até 2031, com um CAGR de 6,61% durante o período de previsão de 2024 a 2031.

Âmbito do relatório e segmentação de mercado       

Definição de mercado de hormonas bioidênticas

Bioidentical hormones are manmade hormones which are used to treat low or out of balance hormonal levels. Bioidentical hormones are similar to the hormones that are naturally produced in the body of both men and women. Bioidentical hormones are used to treat the hormonal imbalance and its effects on and in the body. Normally, hormonal imbalance in men is experienced after 40 years of age.

Bioidentical Hormones Market Dynamics

Drivers

• The rise in the prevalence of hormonal deficiency

Surging prevalence of hormonal deficiency especially in women all around the globe owing to various internal and external factors is one of the major factors responsible for fostering growth of the market. Rising patient pool especially in the developing economies is carving the way for the growth of the market.

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies have led to the advancements in the medical technology and have improved the quality of healthcare facilities.  Increasing number of screening tests for research proficiencies has further widened the scope of growth.

• Government investments on healthcare infrastructure

The increase in the funding by the federal government is set to drive the growth of the market. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative personal health devices market growth opportunities. Also, growing acceptance of bioidentical hormones replacement therapy by the governmental healthcare facilities is also bolstering the market growth rate.

Additionally, surge in the personal disposable income level, introduction of technologically driven product in hospitals and increasing investment for the development of advanced and rise in focus on women health care and treatment of hormonal imbalances, positively affect the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, increasing need for improvised healthcare services owing to imbalance between health workforce and patients and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising lifestyle changes, increased stress and work pressure, irregular eating habits, and lack of exercise, growing number of hospitals and laboratories, rising geriatric population base, rising number of cross-industry partnerships and collaborations and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, safety issues related to the use of compound bioidentical hormones and difficulties related with the medical procedures are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, various side effects such as weight loss and blurred vision, high risk of heart attack and breast cancer and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This bioidentical hormones market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bioidentical hormones market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Bioidentical Hormones Market

Covid-19 has had a negative impact on the market. Reduced focus on non-essential medical procedures and postponement of healthcare procedures has put a dent on the market growth rate. Moreover, halt on the number of research and development proficiencies further restricted the scope of growth in the pandemic phase.  

Bioidentical Hormones Market Scope

The bioidentical hormones market is segmented on the basis of type, product type, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Estrogens
• Progesterone
• Testosterone
• Combined Hormones
• Others

On the basis of type, the bioidentical hormones market is segmented into estrogens, progesterone, testosterone, combined hormones and others.

Product type

• Tablets and Capsules
• Creams and Gels
• Injectable
• Patches and Implants
• Others

Based on product type, the bioidentical hormones market is segmented into tablets and capsules, creams and gels, injectable, patches and implants and others. 

Distribution channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

On the basis of distribution channel, the bioidentical hormones market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

End user

• Hospital
• Gynaecology Clinics
• Academic and Research
• Others

The end user segment of the bioidentical hormones market is segmented into hospital, gynaecology clinics, academic and research and others.

Bioidentical Hormones Market Regional Analysis

The bioidentical hormones market is analysed and market size insights and trends are provided by country, type, product type, distribution channel and end user as referenced above.

The countries covered in the bioidentical hormones market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the bioidentical hormones market because of the strong base of healthcare facilities, availability of reimbursements, rising geriatric population, high healthcare spending combined with the onset of COVID-19 pandemic and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, ever-rising geriatric population base and the growing demand for quality healthcare in the region.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Crescimento da infraestrutura de saúde Base instalada e penetração de novas tecnologias

O mercado das hormonas bioidênticas também fornece análises de mercado detalhadas para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado das hormonas bioidênticas, impacto da tecnologia utilizando curvas de linha de vida e alterações nos cenários regulamentares de saúde e o seu impacto no mercado das hormonas bioidênticas. Os dados estão disponíveis para o período histórico 2010-2020.

Participação no mercado de hormonas bioidênticas

O panorama competitivo do mercado das hormonas bioidênticas fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado das hormonas bioidênticas.

Os líderes de mercado das hormonas bioidênticas que operam no mercado são:

• SottoPelle (EUA)
• Novartis AG (Suíça)
• Orion Pharma AB (Suécia)
• Full Life Wellness Center (EUA)
• BioTE Medical, LLC (EUA)
• Merck KGaA (Alemanha)
• (EUA)
• TherapeuticsMD, Inc.
• Papillon Medical (Canda)
• Farmácia Unida (EUA)
• Noven Pharmaceuticals, Inc.
• Grupo GEA Aktiengesellschaft (Alemanha)
• Novo Nordisk A/S (Dinamarca)
• GeneScience Pharmaceuticals Co., Ltd.
• Actiza Pharmaceutical Private Limited (Índia)
• Desafiar a Medicina (EUA)
• Estética Neuva (EUA)
• Laboratório ZRT (EUA)
• Bayer AG (Alemanha)
• Allergan (Irlanda)

Últimos desenvolvimentos no mercado das hormonas bioidênticas

• Em agosto de 2020, a FDA dos EUA aprovou o Sogroya (somapacitan), uma terapia com hormona de crescimento humano (HGH) para doentes adultos com deficiência de hormona de crescimento, que está indicada para ser tomada uma vez por semana por injeção sob a pele .
• Em dezembro de 2020, a FDA dos EUA aprovou a solução oral de Thyquidity (levotiroxina), da VistaPharm, para terapêutica de substituição de doenças congénitas primárias (tiroideias), secundárias (hipófise) e terciárias (hipotalâmicas).
• Em dezembro de 2020, a FDA dos EUA aprovou o Orgovyx (relugolix) da Myovant Sciences, que é um tratamento administrado por via oral.
• Em agosto de 2020, a Bayer AG anunciou a aquisição da KanDy Therapeutics Inc., que auxilia na expansão do portefólio de medicamentos femininos da Bayer, acrescentando o medicamento para a menopausa da KanDy ao seu portefólio.

SKU-13211